Incyte Corporation Stock Analysis & AI Score
Incyte Corporation (INCY) has an ST Score of 59.2 (B-), driven by its Profitability (A+) and held back by its Valuation (F). Analysts rate it Buy with a $134.40 price target (+15.3% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
AI Daily Briefing
Analysis by AIINCY Stock Price History
INCY Technical Indicators
FMPEarnings Surprises
Analyst Forecast
Revenue Mix
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Analyst Price Target
ESG Score
INCY Latest Stock News
ST Score
Incyte Corporation (INCY) has an ST Score of 59.2 (B-), driven by its Profitability (A+) and held back by its Valuation (F). Analysts rate it Buy with a $134.40 price target (+15.3% upside).
- Strongest
- ProfitabilityA+
- Weakest
- ValuationF
All factor grades
- ProfitabilityA+
- MomentumA
- GrowthB
- Financial StrengthB-
- ForecastC+
- ValuationF
- Piotroski6/9
Press Releases
Company Contact Details
INCY stock: frequently asked questions
What is INCY's ST Score?
Incyte Corporation (INCY) has an ST Score of 59.2 (B-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is INCY a buy, hold, or sell?
Analysts rate INCY a Buy, with a price target of $134.40 (+15.3% vs the current price). Our ST Score grades it B- (59.2/100). The ST Score is a data-driven signal, not a recommendation.
What are INCY's factor grades?
Valuation F, Profitability A+, Financial Strength B-, Momentum A, Growth B, Forecast C+.
What is INCY's valuation grade?
Incyte Corporation (INCY) earns a valuation grade of F, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is INCY's growth grade?
Incyte Corporation (INCY) earns a growth grade of B, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is INCY's profitability grade?
Incyte Corporation (INCY) earns a profitability grade of A+, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is INCY's financial strength grade?
Incyte Corporation (INCY) earns a financial strength grade of B-, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for INCY?
The average analyst price target for Incyte Corporation (INCY) is $134.40 from 44 analysts, which is +15.3% versus the recent price of $116.61.
What is INCY's Piotroski score?
Incyte Corporation (INCY) has a Piotroski F-Score of 6 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.